Bicycle Therapeutics BCYC
NASDAQ BCYC
$3.69 +0.00 (+0.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Bicycle Therapeutics (BCYC) Current Leases (2019 - 2026)

Updated

Bicycle Therapeutics' Current Leases came in at $205,000 for Q4 2025, up 17.1% from $175,000 a year earlier.

Analysis

Bicycle Therapeutics (BCYC) Current Leases (2019 - 2026) Analysis & Trends

Going back to Q3 2024, Bicycle Therapeutics' Current Leases data covers 5 quarters.

  • Going back by year, Current Leases was $175,000 in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Bicycle Therapeutics 258.27 Mn -1.91 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -770,000.00
Mar 31, 2026 -1.26 Mn
Dec 31, 2025 205,000.00
Sep 30, 2025 -199,000.00
Jun 30, 2025 199,000.00
Mar 31, 2025 184,000.00
Dec 31, 2024 175,000.00
Sep 30, 2024 182,000.00
Mar 31, 2020 636,000.00
Dec 31, 2019 640,000.00
API Access

Bicycle Therapeutics Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=BCYC&period=max&api_key=YOUR_API_KEY